Search results for "Permanent prostate brachytherapy"

showing 2 items of 2 documents

Permanent seed brachytherapy for clinically localized prostate cancer: long-term outcomes in a 700 patient cohort.

2015

Abstract Purpose Few large European studies have evaluated long-term outcomes for permanent prostate brachytherapy (PPB) as monotherapy for clinically localized prostate cancer. The objective of the present study was to evaluate long-term survival in this patient profile. Methods and Materials Retrospective study of 700 patients who underwent transperineal ultrasound-guided iodine-125 PPB (145 Gy) between January 2000 and July 2012. Median age was 64.8 years (range, 35–79). Most patients (638 of 700; 91%) had low-risk disease (D'Amico criteria). Eighty-five patients (12%) received hormonal treatment. Overall survival, cause-specific survival, and biochemical relapse–free survival were calcu…

OncologyAdultMalemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentBrachytherapyBrachytherapyUrologyPermanent prostate brachytherapyKaplan-Meier EstimateCohort StudiesIodine RadioisotopesProstate cancerInternal medicineOverall survivalmedicineLong term outcomesHumansRadiology Nuclear Medicine and imagingAgedRetrospective StudiesAged 80 and overbusiness.industryProstatic NeoplasmsRetrospective cohort studyMiddle Agedmedicine.diseaseConfidence intervalTreatment OutcomeOncologyCohortbusinessFollow-Up StudiesBrachytherapy
researchProduct

The use of nomograms in LDR-HDR prostate brachytherapy

2011

Purpose: The common use of nomograms in Low Dose Rate (LDR) permanent prostate brachytherapy (BT) allows to estimate the number of seeds required for an implant. Independent dosimetry verification is recommended for each clinical dosimetry in BT. Also, nomograms can be useful for dose calculation quality assurance and they could be adapt ed to High Dose Rate (HDR). This work sets nomograms for LDR and HDR prostate-BT implants, which are applied to three different institutions that use different implant techniques. Material and methods: Patients treated throughout 2010 till April 2011 were considered for this study. This exam ple was chosen to be the representative of the latest implant tech…

medicine.medical_specialtygenetic structuresbusiness.industrymedicine.medical_treatmentlcsh:RBrachytherapylcsh:MedicinePermanent prostate brachytherapyquality assuranceNomogramprostate brachytherapyKermaOncologymedicineDosimetryOriginal ArticleRadiology Nuclear Medicine and imagingMedical physicsbusinessDose rateindependent verificationQuality assuranceProstate brachytherapynomogramsJournal of Contemporary Brachytherapy
researchProduct